4 December 2018Patents

SCOTUS likely to reverse Helsinn v Teva ruling, say lawyers

The US Supreme Court will today hear a patent dispute between Helsinn Healthcare and Teva Pharmaceuticals, with lawyers telling WIPR that the probable reversal in the case will have a wide-ranging impact.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

US Supreme Court says confidential sales can invoke on-sale bar

22 January 2019 Companies that sell their inventions to third parties under confidential agreements may still end up invalidating their own patents based on the “on-sale” provision, the US Supreme Court said today.

Patents

SCOTUS ruling on confidential sales: lawyers comment

23 January 2019 A decision by the US Supreme Court yesterday will mean no change to the long-standing rules that apply to the “on-sale” bar, but may reduce the incentive for inventors to carry out confidential sales of their inventions, lawyers have told WIPR.

The new president will need to get tough on trade secrets

Timing it right: When to raise issues in an IP dispute

PierFerd hires ‘standout’ prosecutor and AI expert

Going off-track: NASCAR, DraftKings and NBA face down secrets theft

Steptoe bags major patent litigator

‘Works for hire’ exception takes centre stage in 2 Live Crew’s copyright victory

MetaBirkins appeal resurrects ‘fair use’ NFTs debate

Akerman hires licensing and litigation expert duo in New York

SCOTUS likely to reverse Helsinn v Teva ruling, say lawyers

More on this story

Editor's picks

Editor's picks

More articles